CDKN2A and melanoma: In human melanoma cells, the inactivation of the p16 pathway (encoded by the CDKN2A gene) and mutations occurring in the telomerase reverse transcriptase (TERT) promoter may be required for the melanoma to successfully avoid senescence [21].